Deinove

Latest news

19.11.2020

DEINOVE signs an Evaluation and Technology Development License with DSM

DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that pioneers the application of...

12.11.2020

DEINOVE selected for a presentation at the C Diff Foundation annual Conference 2020

Yannick Pletan to present the DNV3837 mechanism of action, key features of the antibiotic candidate...

More press releases

Antibiotic resistance, a global health challenge

The development of antibiotic resistance is, according to international organizations and governments, one of the major health challenges of the 21st century

More info

In the Medias

12.05.2020

Cdiff Foundation | A New Parenteral Treatment for a Severe C. difficile Infection

"A New Parenteral Treatment for a Severe C. difficile Infection" hosted by Nancy C. Caralla Join us with our two guests: Dr Yannick Pletan...

08.05.2020

Biotech & Finance | Alexis Rideau, arrive chez Deinove avec son réseau industriel et académique de pointe

C’est une nouvelle aventure pour Alexis Rideau, qui occupe depuis cette semaine la fonction de directeur général délégué de Deinove...

More press coverage

Disruptive innovation

Latest news

Antibiotic resistance, a global health challenge

In the Medias